{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T03:16:43Z","timestamp":1764645403141},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,1]]},"DOI":"10.1093\/ckj\/sfy114","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T15:15:47Z","timestamp":1539702947000},"page":"78-80","source":"Crossref","is-referenced-by-count":9,"title":["Pembrolizumab-related renal toxicities: diagnosis first, treatment later"],"prefix":"10.1093","volume":"12","author":[{"given":"Ben","family":"Sprangers","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology, Laboratory of Experimental Transplantation, KU Leuven, Leuven, Belgium"},{"name":"Department of Nephrology, University Hospitals Leuven, Leuven, Belgium"},{"name":"Cancer-Kidney International Network (C-KIN), Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,12,1]]},"reference":[{"key":"key\n\t\t\t\t2019020706495660800_sfy114-B1","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1200\/JCO.2014.59.4358","article-title":"Immune checkpoint blockade in cancer therapy","volume":"33","author":"Postow","year":"2015","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2019020706495660800_sfy114-B2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1126\/science.aaa8172","article-title":"The future of immune checkpoint therapy","volume":"348","author":"Sharma","year":"2015","journal-title":"Science"},{"key":"key\n\t\t\t\t2019020706495660800_sfy114-B3","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019020706495660800_sfy114-B4","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000455014","article-title":"Adverse renal effects of immune checkpoint inhibitors: a narrative review","volume":"45","author":"Wanchoo","year":"2017","journal-title":"Am J Nephrol"},{"key":"key\n\t\t\t\t2019020706495660800_sfy114-B5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/23809000.2017.1369045","article-title":"Management of checkpoint inhibitor-associated renal toxicities","volume":"2","author":"Vanoverbeke","year":"2017","journal-title":"Expert Rev Qual Life Cancer Care"},{"key":"key\n\t\t\t\t2019020706495660800_sfy114-B6","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.2147\/DDDT.S146286","article-title":"Safety and efficacy profile of pembrolizumab in solid cancer: pooled reanalysis based on randomized controlled trials","volume":"11","author":"Wang","year":"2017","journal-title":"Drug Des Devel Ther"},{"key":"key\n\t\t\t\t2019020706495660800_sfy114-B7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/ckj\/sfy100","article-title":"Renal toxicities associated with pembrolizumab","volume":"12","author":"Izzedine","year":"2019","journal-title":"Clin Kidney J"},{"key":"key\n\t\t\t\t2019020706495660800_sfy114-B8","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.kint.2016.04.008","article-title":"Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors","volume":"90","author":"Cortazar","year":"2016","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2019020706495660800_sfy114-B9","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2016.34.15_suppl.6627","article-title":"Modeling the cost of immune checkpoint inhibitor-related toxicities","volume":"34","author":"Mason","year":"2016","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2019020706495660800_sfy114-B10","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1056\/NEJMra1613984","article-title":"Acute kidney injury in patients with cancer","volume":"376","author":"Rosner","year":"2017","journal-title":"N Engl J Med"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ckj\/article-pdf\/12\/1\/78\/27721504\/sfy114.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T07:24:53Z","timestamp":1549524293000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/12\/1\/78\/5224970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,1]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12,1]]},"published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfy114","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,2]]},"published":{"date-parts":[[2018,12,1]]}}}